Genenta Science S.p.A.
GNTA | NASDAQ
$0.69
+$0.01 (+1.89%)
Sep 22, 2026, 12:28 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 41.58K | 6.03K | 5.08K | 1.77K | n/a |
Gross Profit | n/a | -41.58K | -6.03K | -5.08K | -1.77K | n/a |
Operating Income | -9.76M | -11.73M | -11.04M | -5.69M | -5.59M | -4.62M |
Interest Income | 81.14K | n/a | 36.98 | 11.72 | 7.75 | 9.55 |
Pretax Income | -8.91M | -11.65M | -8.48M | -5.53M | -5.59M | -4.6M |
Net Income | -8.91M | -11.65M | -8.48M | -5.53M | -5.61M | -4.61M |
Selling & General & Admin | 4.95M | 5.26M | 5.71M | 2.3M | 901.77K | 921.52K |
Research & Development | 4.81M | 6.47M | 5.34M | 3.39M | 4.69M | 3.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.76M | 11.73M | 11.04M | 5.69M | 5.59M | 4.62M |
Interest Expense | n/a | n/a | n/a | 11.72K | 7.75K | 9.55K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.76M | 11.73M | 11.04M | 5.69M | 5.59M | 4.62M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M | 18.12M |
Shares Outstanding (Diluted) | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M | 18.12M |
EPS (Basic) | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 | -0.25 |
EPS (Diluted) | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 | -0.25 |
EBITDA | -9.72M | -11.69M | -11.04M | -5.68M | -5.59M | n/a |
EBIT | -9.76M | -11.73M | -11.04M | -5.69M | -5.59M | -4.62M |
Depreciation & Amortization | 44.52K | 42.45K | 6.03K | 5.08K | 1.77K | 4.62M |
Add to Watchlist
Select watchlists to add or remove GNTA